Advisory Research’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q1
Sell
-5,926
Closed -$502K 365
2018
Q4
$502K Sell
5,926
-2,499
-30% -$212K 0.01% 294
2018
Q3
$1.44M Sell
8,425
-6,295
-43% -$1.08M 0.02% 230
2018
Q2
$1.9M Sell
14,720
-42
-0.3% -$5.43K 0.03% 217
2018
Q1
$1.52M Buy
+14,762
New +$1.52M 0.03% 235